查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392033

个人化基因组学市场：按测试类型、按技术、按应用、按最终用户、按地区

Personalized Genomics Market, By Test Type, By Technology, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球个人化基因组学市场规模预计将从 2023 年的 91.4 亿美元增加到 2030 年的 277.7 亿美元，预测期内复合年增长率为 17.2%。

报告范围 报告详情
基准年 2022年 2023年市场规模 91.4亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 17.20% 2030年市场规模预测 277.7亿美元
图 1. 个人化基因体学的全球市场占有率(%)（按地区），2023 年
个性化基因组市场-IMG1

个人化基因组学是一个快速发展的领域，它将遗传学、基因组学和个人化医疗结合起来，为个体的基因组成提供有价值的见解。

市场动态：.

全球个人化基因组学市场由多种因素驱动。首先，慢性病的增加和对个体化治疗方案的需求正在推动对基因检测服务的需求。个体化基因组学可以帮助识别患有特定疾病的高风险个体，从而进行早期疗育和有针对性的治疗。例如，根据 2020 年 9 月发表在《预防慢性病》上的一篇论文，2018 年，一般大众中 51.8% 的非住院成年人被诊断出至少患有 10 种选定的慢性病中的一种。具体而言，24.6%的成年人患有一种慢性病，27.2%的成年人患有两种或两种以上慢性病。

此外，次世代定序和生物资讯学等技术的进步使基因检测变得更加容易和负担得起。因此，提供个人化基因组学服务的公司拥有不断增长的消费群。

但市场也存在一定的抑制因素。人们对隐私和资料安全表示担忧，因为遗传资讯高度敏感，如果保护不当，可能会被滥用。监管挑战以及对遗传资料使用和解释的明确指南的需求也对市场成长构成挑战。

儘管存在这些挑战，个体化基因组学市场仍存在重大机会。将人工智慧和机器学习演算法与遗传分析相结合可以提高个体化基因组学服务的准确性和效率。此外，直接面向消费者的基因检测的扩展以及医疗保健环境中基因检测的日益采用为该市场的公司提供了充满希望的成长前景。

本研究的主要特点

  • 本报告对全球个体化基因组市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030）的市场规模和复合年增长率。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球个人化基因组市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出资讯的决策。
  • 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球个体化基因组市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 个人化医疗需求不断成长，研发投入不断增加
    • 高成本和复杂的资料解释
    • 利用巨量资料和人工智慧
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球个人化基因组市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球个人化基因组市场，依测试类型，2018-2030

  • 介绍
  • 肿瘤检查
  • 传染病检查
  • 神经学检查
  • 心血管检查
  • 其他的

第六章 全球个人化基因体市场（按技术），2018-2030

  • 介绍
  • 基于PCR的测试
  • 基于微阵列的测试
  • 基于序列的测试
  • 其他的

第七章 全球个人化基因体学市场，依应用分类，2018-2030

  • 介绍
  • 诊断
  • 精准医疗
  • 健康
  • 生殖健康
  • 运动营养与健康
  • 生活方式
  • 其他的

第 8 章 全球个人化基因组市场，依最终使用者划分，2018-2030 年

  • 介绍
  • 医院和诊所
  • 研究中心
  • 製药和生物技术公司
  • 诊断实验室
  • 其他的

第9章全球个人化基因组市场，按地区，2018-2030

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东和非洲
  • 海湾合作委员会国家
  • 以色列
  • 南非
  • 北非
  • 中部非洲
  • 其他中东地区

第10章竞争形势

  • 23andMe
  • Mapmygenome
  • Invitea
  • Genetic Technology Limited
  • Lonza
  • Interleukin Genetics, Inc
  • GNA Genotek
  • Helix
  • MyHeritage
  • Pathway Genomics
  • Veritas Genetics
  • Xcode
  • Color Genomics
  • Myriad Genetics
  • Quest Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Illumina
  • Thermo Fisher Scientific
  • Qiagen
  • Genomic Health
  • Nebula Genomics

第11章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6210

The global personalized genomics market size is expected to reach US$ 27.77 Billion by 2030, from US$ 9.14 Billion in 2023, at a CAGR of 17.2% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 9.14 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 17.20% 2030 Value Projection: US$ 27.77 Bn
Figure 1. Global Personalized Genomics Market Share (%), By Region, 2023
Personalized Genomics Market - IMG1

Personalized genomics is a rapidly growing field that combines genetics, genomics, and personalized medicine to provide individuals with valuable insights into their genetic makeup.

Market Dynamics:

The global personalized genomics market is driven by several factors. Firstly, the increasing prevalence of chronic diseases and the need for personalized treatment options have created a demand for genetic testing services. Personalized genomics can help identify individuals who are at a higher risk of developing certain diseases, allowing for early intervention and targeted treatment. For instance, in September 2020, according to an article published in Preventing Chronic Disease, in 2018, 51.8% of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. More specifically, the 24.6% of adults have 1 chronic condition, and 27.2% have more than two chronic conditions.

Additionally, advancements in technology, such as next-generation sequencing and bioinformatics, have made genetic testing more accessible and affordable. This has led to a growing consumer base for companies offering personalized genomics services.

However, there are also certain restraints in the market. Concerns about privacy and data security have been raised, as genetic information is highly sensitive and can be misused if not properly protected. Regulatory challenges and the need for clear guidelines regarding the use and interpretation of genetic data also pose challenges to market growth.

Despite these challenges, the personalized genomics market presents significant opportunities. The integration of artificial intelligence and machine learning algorithms in genetic analysis can enhance the accuracy and efficiency of personalized genomics services. Additionally, the expansion of direct-to-consumer genetic testing and the increasing adoption of genetic testing in healthcare settings offer promising growth prospects for companies in this market.

Key features of the study:

  • This report provides in-depth analysis of the global personalized genomics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global personalized genomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Personalized Genomics; 23andMe, Mapmygenome, Invitea, Genetic Technology Limited, Lonza, Interleukin Genetics, Inc, GNA Genotek, Helix, MyHeritage, Pathway Genomics, Veritas Genetics, Xcode, Color Genomics, Myriad Genetics, Quest Diagnostics, Bio-Rad Laboratories, Inc., Illumina, Thermo Fisher Scientific, Qiagen, Genomic Health, Nebula Genomics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global personalized genomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized genomics market

Personalized Genomics Market Detailed Segmentation:

  • By Test Type
    • Oncology Testing
    • Infectious Disease Testing
    • Neurological Testing
    • Cardiovascular Testing
    • Others
  • By Technology
    • PCR-based Tests
    • Microarray-based Tests
    • Sequencing-based Tests
    • Others
  • By Application
    • Diagnostics
    • Precision Medicine
    • Wellness
    • Reproductive Health
    • Sports Nutrition & Health
    • Lifestyle
    • Others
  • By End User
    • Hospitals & Clinics
    • Research Centers
    • Pharmaceutical & Biotechnology Companies
    • Diagnostic Laboratories
    • Others
  • By Region
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa
  • Key Players
    • 23andMe
    • Mapmygenome
    • Invitea
    • Genetic Technology Limited
    • Lonza
    • Interleukin Genetics, Inc
    • GNA Genotek
    • Helix
    • MyHeritage
    • Pathway Genomics
    • Veritas Genetics
    • Xcode
    • Color Genomics
    • Myriad Genetics
    • Quest Diagnostics
    • Bio-Rad Laboratories, Inc.
    • Illumina
    • Thermo Fisher Scientific
    • Qiagen
    • Genomic Health
    • Nebula Genomics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Personalized Genomics, By Test Type
    • Market Personalized Genomics, By Technology
    • Market Personalized Genomics, By Application
    • Market Personalized Genomics, By End User
    • Market Personalized Genomics, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing demand for personalized medicine and increase in R&D investments
    • High costs and complex data interpretation
    • Leveraging Big Data and Artificial Intelligence
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Personalized Genomics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Personalized Genomics Market , By Test Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oncology Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Infectious Disease Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Neurological Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Cardiovascular Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Personalized Genomics Market , By Technology, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • PCR-based Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Microarray-based Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Sequencing-based Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

7. Global Personalized Genomics Market , By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Precision Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Wellness
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Reproductive Health
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Sports Nutrition & Health
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Lifestyle
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

8. Global Personalized Genomics Market , By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Research Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

9. Global Personalized Genomics Market , By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/ Region, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • South Africa
  • North Africa
  • Central Africa
  • Rest of Middle East

10. Competitive Landscape

  • 23andMe
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mapmygenome
  • Invitea
  • Genetic Technology Limited
  • Lonza
  • Interleukin Genetics, Inc
  • GNA Genotek
  • Helix
  • MyHeritage
  • Pathway Genomics
  • Veritas Genetics
  • Xcode
  • Color Genomics
  • Myriad Genetics
  • Quest Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Illumina
  • Thermo Fisher Scientific
  • Qiagen
  • Genomic Health
  • Nebula Genomics
  • Analyst Views

11. Section

  • Research Methodology
  • About us